Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Hepatocellular Carcinoma

Screening for Hepatocellular Carcinoma

Colombo M.

Author affiliations

University of Milan, FIRC-University Research Unit on Liver Cancer, IRCCS Ospedale Maggiore,Milan,Italy

Related Articles for ""

Digestion 1998;59(suppl 2):70–71

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Hepatocellular Carcinoma

Published online: August 17, 1998
Issue release date: July 1998

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)

For additional information: https://www.karger.com/DIG

Abstract

The medical aim of screening is to improve the health of the general population by early detection and treatment of disease. The economic aims are, in the short term, to save the time of highly trained doctors by using technicians or automated procedures, and in the long run, to treat early disease so as to lengthen the productive life of the persons at risk [1]. Thus, screening has been widely spreading as a practical approach to reducing the mortality rate from hepatocellular carcinoma (HCC).


References

  1. Wilson JMG, Jungner G: Principles and Practice of Screening for Disease. Public paper 34. Geneva, World Health Organization, 1968.
  2. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology 1992;5:948–963.
  3. Colombo M: Hepatocellular carcinoma in cirrhotics. Semin Liver Dis 1993;13:374–383.
  4. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Morita M, Saisho H, Tsuchiya Y, Okuda K: Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 1986;90:289–298.
  5. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675–680.
  6. Nousbaum JP, Pol S, Nalpas, B, Landais P, Berthelot P, Brechot C, and the Collaborative Study Group: Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161–168.
  7. Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, Virdone R, Fusco G, Grasso R, Simonetti RC, Pagliaro L: Screening for hepatocellular carcinoma in patients with Child’s A cirrhosis: A 8‐year prospective study by ultrasound and >‐fetoprotein. J Hepatol 1994;21:1029–1034.
  8. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797–1801.
  9. Tradati F, Colombo M, Mannucci PM, Rumi MG, De Fazio C, Gamba C, Ciavarella N, Rocino A, Morfini M, Scaraggi A, Taioli E, and the Study Group of the Association of Italian Hemophilia Centers: A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. Blood 1998;91:1173–1177.
  10. Mc Mahon BJ, London T: Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991;83:916–919.
  11. Colombo M: Early diagnosis of hepatocellular carcinoma in Italy. A summary of a Consensus Development Conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF). J Hepatol 1992;14:401–403.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Hepatocellular Carcinoma

Published online: August 17, 1998
Issue release date: July 1998

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)

For additional information: https://www.karger.com/DIG


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.